Risks of the pill not published

A Dutch radio journalist has found evidence that the drug company Wyeth had discovered that the so called third generation oral contraceptives can increase the risk of thromboembolism.

The link between venous thromboembolism and the third generation Pill is, of course, nothing new. What is important about this finding is that the drug company, after having commissioned the study, decided not to publish it, possibly because of the unfavourable results. Industry sponsored studies have never found an increased risk of venous thromboembolism among third generation Pill users whereas independent researchers have nearly always found a twofold increase. Wyeth claims they did not keep the results of the study a secret and even passed it on to the European Agency for the Evaluation of Medicinal Products (EMEA). The Dutch report maintains that Wyeth only did so after pressure was brought tobear by the German and UK health authorities (Lancet, 2001; 357: 779).

Related WDDTY Content

Third generation pills: more risks, less benefits

Newer third generation birth control pills such as desogestrel or gestodene may not be safer for your heart than their predecessors, as originally pr...

Thromboembolism caused by common antipsychotic drugs

Current use of antipsychotic drugs significantly raises the risk of venous thromboembolism (VTE), say researchers from the Boston University School of...

Newer pill raises risk of blood clots

Doctors have noted that women using third generation birth control have a higher risk of thromboembolism. Now they know why. ...

Health risks of radio signals

Once an expensive novelty, mobile phones are now considered a necessity. The staggering fact is that more people in the UK now own mobile phones than...

Drug and vitamin interactions

The recent attack by UK health authorities on vitamin and mineral supplements was astonishing largely because of the flimsiness of the evidence of so-...

A Typical Deception: New antipsychotics are more expensive, but no more effective

Have the US and UK health authorities been conned yet again by the promise of a ‘new generation’ of better and more effective drugs? Atypical ant...